WALTHAM, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company developing therapies to treat central...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Financials, Technology and Utilities sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Technology, Healthcare and Telecoms sectors propelled shares higher while losses in the Financials,...
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson’s disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Buy | Buy | Strong Sell | Strong Sell | Strong Sell |
| Summary | Neutral | Neutral | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 137.75 | 137.75 | 137.75 | -1.50 | -1.08% | 154.98K | London | |||
| 3,900.00 | 3,952.00 | 3,875.00 | +52.0 | +1.35% | 138.75K | London | |||
| 10.70 | 10.70 | 10.70 | -0.05 | -0.47% | 41.91K | London | |||
| 797.38 | 799.00 | 780.00 | +11.60 | +1.48% | 254.85K | London | |||
| 244.80 | 246.00 | 244.80 | 0.00 | 0.00% | 0.00 | London | |||
| 125.68 | 126.70 | 122.10 | +3.60 | +2.95% | 870.19K | London | |||
| 6.29 | 6.38 | 5.50 | 0.00 | 0.00% | 0.00 | London | |||
| 696.20 | 706.00 | 689.00 | +19.80 | +2.93% | 175.22K | London | |||
| 1,435.50 | 1,450.00 | 1,426.50 | +13.00 | +0.91% | 351.02K | London | |||
| 624.98 | 631.50 | 611.00 | +4.98 | +0.80% | 24.26K | London | |||
| 2.20 | 2.22 | 2.19 | +0.01 | 0.00% | 148.11K | London | |||
| 669.60 | 687.80 | 655.00 | +0.40 | +0.06% | 29.11K | London | |||
| 35.50 | 35.50 | 35.50 | 0.00 | 0.00% | 0.00 | London | |||
| 1,284.50 | 1,294.00 | 1,268.50 | +12.00 | +0.94% | 448.19K | London | |||
| 10,367.20 | 10,582.40 | 10,367.20 | -27.8 | -0.27% | 2.45K | London |